BridgeBio Pharma Inc.
BBIO
NGS
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
11.09
USD
-0.84
(-7.04%)
Optionable: Yes Market Cap: 1,329 M 90-day average vol: 2,333,828
Previous close: 11.93 Open: 11.6 Bid: 11.76 Ask: 11.76
52 week range
4.98 53.57
Last updated: Wednesday 10th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Some Analysts Just Cut Their BridgeBio Pharma, Inc. (NASDAQ:BBIO) Estimates
Yahoo Finance 3/1/2022
BridgeBio Pharma (BBIO) Presents At Global Healthcare Virtual Conference - Slideshow
Seeking Alpha 2/25/2022
BridgeBio Pharma (BBIO) Reports Q4 Loss, Misses Revenue Estimates
Yahoo Finance 2/24/2022
BridgeBio Pharma GAAP EPS of -$1.01 misses by $0.16, revenue of $12.89M misses by $8.69M
Seeking Alpha 2/24/2022
BridgeBio Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
Yahoo Finance 2/24/2022
Will BridgeBio Pharma (BBIO) Report Negative Q4 Earnings? What You Should Know
Yahoo Finance 2/17/2022
BridgeBio (BBIO) to Report Q4 Earnings: What's in the Cards?
Yahoo Finance 2/17/2022
BridgeBio Pharma (BBIO) Dips More Than Broader Markets: What You Should Know
Yahoo Finance 2/14/2022
BridgeBio Pharma (BBIO) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance 2/4/2022
BridgeBio Pharma (BBIO) Gains But Lags Market: What You Should Know
Yahoo Finance 1/28/2022
BridgeBio (BBIO) Begins Dosing with Gene Therapy in CAH Study
Yahoo Finance 1/28/2022
BridgeBio begins dosing of gene therapy in phase 1/2 trial for adrenal gland disorder
Seeking Alpha 1/27/2022
BridgeBio Pharma Announces Dosing of First Patient in Phase 1/2 Trial of Investigational Gene Therapy for Congenital Adrenal Hyperplasia (CAH)
Yahoo Finance 1/27/2022
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
Yahoo Finance 1/25/2022
BridgeBio Pharma (BBIO) Investor Presentation - Slideshow
Seeking Alpha 1/24/2022
BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study
Yahoo Finance 1/14/2022
BridgeBio partners with Amgen for a combination study involving cancer candidate
Seeking Alpha 1/13/2022
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!